Editorial · 7 Apr 2021
Review articlePublished 2016
Kava as a Pharmacotherapy of Anxiety Disorders: Promises and Concerns
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Current standard pharmacotherapies for anxiety management come with a host of side-effects that may deter the patients from utilizing them. Kava, a traditional beverage from the South Pacific region, has been used as a natural medicine for centuries and has been hypothesized to contain anxiolytic properties. There are a few well-designed, randomly controlled trials that have evaluated the effectiveness of kava or its constituents against anxiety disorders. They have generally shown kava to be effective in managing the disease. However, there has been a serious concern about the hepatotoxic risk of kava, which greatly limits its anxiolytic development and application. This review attempts to summarize the recent anxiolytic trials using kava, the associated hepatotoxicity risks, the potential responsible chemicals for these two activities, and the mechanisms of action. Overall, kava has a great potential to be developed as a natural anxiolytic agent through a systematic approach, but the present form should be used with caution.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Jul 2017
Somatostatin receptor subtype-4 is a promising drug target on neurons for treatment of pain, anxiety, depression and cognitive disorders
Conference abstract · 2020
New Herbal Treatment for depression and Anxiety Disorders with minimal side-effects increase BDNF level in the hippocampus
Short communication · 20 Feb 2021
Importance of pharmacotherapy in OCD(obsessive compulsive disorder) patients
Review article · 28 Apr 2023
Title: The potential of cannabidiol (CBD) as a treatment for anxiety disorders
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Zachary Rivers”
- BylineArticles whose byline prints “Chengguo Xing”
- BylineArticles whose byline prints “Sreekanth Narayanapillai”

